Depression, antidepressants, and bone mineral density in a population-based cohort

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 63, Issue 12, 2008, Pages 1410-1415

  Mezuk, Briana ^a,d   Eaton, William W ^b   Golden, Sherita Hill ^b,c   Wand, Gary ^b   Lee, Hochang Benjamin ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d 109 South Observatory   (United States)

Author keywords

Antidepressants; Bone mineral density; Cohort study; Depression; Osteoporosis

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY FAT; BONE DENSITY; CALCIUM INTAKE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC INTERVIEW SCHEDULE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING;

EID: 62149091793     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/63.12.1410     Document Type: Article

References (26)

1. U.S. Department ofHealth and Services. Bone health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General; 2004.
2. Forsen L, Sogaard A, Meyer H, et al. Survival after hip fracture: short and long-term excess mortality according to age and gender. Osteoporos Int. 1999;10:73-78.
3. Kessler R, Berglund P, Delmer O, et al. Lifetime prevalence and age- of-onset distributions of DSM-IV disorders in the National Comorbid- ity Survey Replication. Arch Gen Psychiatry. 2005;62:593-602.
4. Cizza G. Depression: a major, unrecognized risk factor for osteoporosis? In: Eaton WW, ed. Medical and Psychiatric Comorbidity over the Course of Life. Arlington, VA: American Psychiatric Publishing, Inc.; 2006:129-153.
5. Mezuk B, Eaton WW, Golden S. Depression and osteoporosis: epidemiology and potential mediating pathways. Osteoporos Int. 2008; 19:1-12.
6. Landi F, Onder G, Cesari M, et al. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci. 2005;60:622-626.
7. Takkouche B, Montes-Martinez A, Gill S, et al. Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf. 2007; 30:171-184.
8. Warden S, Robling A, Sanders M, et al. Inhibition of the serotonin (5- hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology. 2005;146:685-693.
9. Battaglino R, Vokes M, Schulze-Spate U, et al. Fluoxetine treatment increases trabecular bone formation in mice. J Cell Biochem. 2007; 100:1387-1394.
10. Cauley J, Fullman R, Stone K, et al. Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int. 2005;16:1525-1537.
11. Haney E, Chan B, Diem S, et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med. 2007;167:1246-1251.
12. Richards J, Papaioannou A, Adachi J, et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med. 2007;167:188-194.
13. Diem S, Blackwell T, Stone K, et al. Use of antidepressants and rates of hip bone loss in older women. Arch Intern Med. 2007;167: 1240-1245.
14. Kinjo M, Setoguchi S, Schneeweiss S, et al. Bone mineral density in subjects using central nervous system-active medications. Am J Med. 2005;118:1414.
15. Regier D, Myers J, Kramer M, et al. The NIMH Epidemiologic Catchment Area program: historical context, major objectives, and study population characteristics. Arch Gen Psychiatry. 1984;41: 934-941.
16. Robins L, Helzer J, Croughan J, et al. National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics and validity. Arch Gen Psychiatry. 1981;38:381-389.
17. Eaton WW, Neufeld K, Chen L, et al. A comparison of self-report and clinical diagnostic interviews for depression: Diagnostic Interview Schedule and Schedules for Clinical Assessment in Neuropsychiatry in the Baltimore Epidemiologic Catchment Area followup. Arch Gen Psychiatry. 2000;57:217-222.
18. Yesavage J, Brink T, Rose T, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1983;17:37-49.
19. Melton LJ 3rd, Looker A, Shepherd J, et al. Osteoporosis assessment by whole body region vs. site-specific DXA. Osteoporos Int. 2005;16: 1558-1564.
20. Physicians' Desk Reference (PDR). Oradell, NJ: Medical Economics Co., 2006.
21. Washburn R, Smith K, Jette A, et al. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993; 46:152-162.
22. Ravaglia G, Forti P, Maioli F, et al. Measurement of body fat in healthy elderly men: a comparison of methods. J Gerontol A Biol Sci Med Sci. 1999;54A:M70-M76.
23. Bolanowski M, Nilsson B. Assessment of human body composition using dual-energy x-ray absorptiometry and bioelectrical impedance analysis. Med Sci Monit. 2001;7:1029-1033.
24. Efron B, Tibshirani R. Bootstrap measures for standard errors, confidence intervals and other measures of statistical accuracy. Stat Sci. 1986;1:54-77.
25. World Health Organization. Assessment of fracture risk and its application to screening for post-menopausal osteoporosis: report of the WHO study group. World Health Org Tech Rep Ser. 1994;843:1-126.
26. Paulose-Ram R, Safran M, Jonas B, et al. Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiol Drug Saf. 2007;16:560-570.